Publications by authors named "Jill Blim"

Claim this Profile
E
Economic Impact of Anti-Vascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database.
Ella H Leung, Saira Khanna, Michael M Lai, Charles Wykoff, J Michael Jumper, Jill Blim

J Vitreoretin Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab First in DRCR Protocol AC vs Real-World Physician Treatment Choice for Diabetic Macular Edema: Two-Year Cost Analysis.
Dilraj S Grewal, Ella Leung, Miguel Busquets, Philip Niles, Dan A Gong, Jill Blim

J Vitreoretin Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World Practice.
Ella H Leung, Dilraj S Grewal, Emanuel Gerbi, Miguel Busquets, Philip Niles, Jill Blim

J Vitreoretin Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists.
Hasenin Al-Khersan, Miguel Busquets, Ghassan Ghorayeb, Dan Gong, Anton Kolomeyer, Jill Blim

J Vitreoretin Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices.
Sabin Dang, D Wilkin Parke, Guneet S Sodhi, David Eichenbaum, Jared Nielsen, Jill Blim

JAMA Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Broader Economic Value of Treatment for Diabetic Macular Edema.
Karen Mulligan, Jaehong Kim, Bryan Tysinger, Jill Blim, Geoffrey Emerson

Diabetes Care· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunity Cost of Vitreoretinal Surgeries.
Ella H Leung, Shriji Patel, Rahul Reddy, Nick Boucher, Chakshu Sharma, Jill Blim

J Vitreoretin Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Medicare Reimbursement for Common Vitreoretinal Procedures: 2011 to 2020.
Nicolaas P DeRuyter, Shriji Patel, Qingxia Chen, Henry Leder, Ella Leung, Jill Blim

Ophthalmology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunity Cost of Retinal Detachment Surgery vs Office-Based Patient Care.
Ella H Leung, Henry A Leder, Shriji Patel, Rahul Reddy, Nick Boucher, Jill Blim

J Vitreoretin Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their Patients.
Paul Hahn, Jill F Blim, Kirk Packo, J Michael Jumper, Timothy Murray

J Vitreoretin Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the Editors.
Donald J D'Amico, Timothy G Murray, Jill F Blim

J Vitreoretin Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Value of Anti-Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States.
Karen Mulligan, Seth A Seabury, Pravin U Dugel, Jill F Blim, Dana P Goldman

JAMA Ophthalmol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular Degeneration.
Kristina B Lindsley, Susan Hutfless, Barbara S Hawkins, Jill F Blim, Dan Roberts

JAMA Ophthalmol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis